BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17286037)

  • 1. [Preselection procedure for medical devices suppliers at the essential medicines and generic drugs purchasing central in Togo (CAMEG-Togo)].
    Babaley M
    Med Trop (Mars); 2006 Dec; 66(6):623-30. PubMed ID: 17286037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Access to essential medicines in Africa: a global approach].
    Millot G
    Med Trop (Mars); 2006 Dec; 66(6):558-64. PubMed ID: 17286021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs.
    Chaudhury RR; Parameswar R; Gupta U; Sharma S; Tekur U; Bapna JS
    Health Policy Plan; 2005 Mar; 20(2):124-36. PubMed ID: 15746221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices manufactured from latex: European regulatory initiatives.
    De Jong WH; Geertsma RE; Tinkler JJ
    Methods; 2002 May; 27(1):93-8. PubMed ID: 12079423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Medical devices and European regulations"].
    Fleur F
    Ann Pharm Fr; 1997; 55(2):73-6. PubMed ID: 9181704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting US and European supplier control requirements.
    Donawa M
    Med Device Technol; 2009; 20(3):24-7. PubMed ID: 19626952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal aspects of E-HEALTH.
    Callens S; Cierkens K
    Stud Health Technol Inform; 2008; 141():47-56. PubMed ID: 18953124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals--strategic considerations in health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S100-11. PubMed ID: 17595837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purchasing silicone.
    Pryce T
    Med Device Technol; 1996 Mar; 7(2):22-6, 28. PubMed ID: 10184584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What the Internet means for the medical device industry.
    Frank T
    Med Device Technol; 2000 Dec; 11(10):56-7, 60-1. PubMed ID: 11200157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan.
    Al-Abbadi I; Qawwas A; Jaafreh M; Abosamen T; Saket M
    Clin Ther; 2009 Jun; 31(6):1335-44. PubMed ID: 19695398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution to the establishment of quality assurance in five medical microbiology departments in Togo].
    Katawa G; Kpotsra A; Karou DS; Eklou M; Tayi KE; de Souza C
    Bull Soc Pathol Exot; 2011 Feb; 104(1):20-4. PubMed ID: 21174238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
    Tetteh Ek
    Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The harmonization of the regulation of blood products: a European perspective.
    Seitz R; Heiden M; Nübling CM; Unger G; Löwer J
    Vox Sang; 2008 May; 94(4):267-76. PubMed ID: 18179678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug supply strategies, constraints and prospects in Nigeria.
    Yusuff KB; Tayo F
    Afr J Med Med Sci; 2004 Dec; 33(4):389-94. PubMed ID: 15977451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing adoption and affordability of medical devices in Europe.
    Schreyögg J; Bäumler M; Busse R
    Health Policy; 2009 Oct; 92(2-3):218-24. PubMed ID: 19410326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.